Here's the live share price of Windlas Biotech along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Windlas Biotech | 2.95 | 4.39 | 14.30 | 11.31 | -9.37 | 44.86 | 15.47 |
| Sun Pharmaceutical Industries | -0.53 | -4.91 | -1.50 | 0.24 | 5.09 | 21.89 | 21.49 |
| Divi's Laboratories | 3.52 | 0.65 | 6.65 | 7.40 | 1.99 | 25.40 | 9.64 |
| Torrent Pharmaceuticals | 3.52 | -1.17 | 2.18 | 18.69 | 40.48 | 35.21 | 26.17 |
| Zydus Lifesciences | 2.68 | 15.62 | 21.73 | 20.24 | 13.63 | 29.68 | 11.71 |
| Cipla | -0.16 | 5.52 | 3.89 | -7.64 | -8.60 | 12.43 | 7.51 |
| Dr. Reddy's Laboratories | -0.46 | -0.86 | -1.37 | 1.81 | -3.83 | 10.75 | 3.97 |
| Lupin | 0.33 | 0.51 | -1.94 | 9.99 | 13.21 | 40.89 | 13.10 |
| Mankind Pharma | 3.98 | -3.21 | 10.54 | 9.68 | 1.43 | 17.25 | 10.91 |
| Aurobindo Pharma | 1.18 | -2.68 | 15.97 | 24.47 | 24.51 | 29.29 | 8.58 |
| Laurus Labs | 2.82 | 12.29 | 39.30 | 39.23 | 113.18 | 60.98 | 18.43 |
| Biocon | 0.02 | 6.72 | 6.91 | 8.66 | 23.26 | 20.05 | 0.60 |
| Alkem Laboratories | 2.17 | -4.39 | -1.97 | -5.51 | 9.81 | 16.20 | 11.56 |
| Glenmark Pharmaceuticals | 0.84 | -6.25 | 4.08 | 13.66 | 37.83 | 51.31 | 28.74 |
| Abbott India | -0.48 | -5.80 | -3.66 | -6.95 | -17.75 | 6.26 | 10.24 |
| Anthem Biosciences | 2.83 | -1.15 | 17.42 | 17.72 | 6.11 | 2.00 | 1.19 |
| Ipca Laboratories | 8.39 | 6.57 | 8.47 | 12.63 | 19.39 | 30.92 | 9.88 |
| Gland Pharma | 0.71 | 19.33 | 36.40 | 33.83 | 39.02 | 33.71 | -5.89 |
| Ajanta Pharma | 2.96 | -2.05 | 2.33 | 14.61 | 15.61 | 27.19 | 18.58 |
| GlaxoSmithKline Pharmaceuticals | 0.29 | -9.91 | -12.97 | -14.28 | -35.38 | 17.02 | 8.16 |
Source: Dion Global
Over the last one year, Windlas Biotech has declined 9.37% compared to peers like Sun Pharmaceutical Industries (5.09%), Divi's Laboratories (1.99%), Torrent Pharmaceuticals (40.48%). From a 5 year perspective, Windlas Biotech has outperformed peers relative to Sun Pharmaceutical Industries (21.49%) and Divi's Laboratories (9.64%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 811.1 | 811.74 |
| 10 | 810.63 | 809.36 |
| 20 | 796.62 | 809.28 |
| 50 | 811.89 | 807.85 |
| 100 | 798.71 | 811.08 |
| 200 | 845.37 | 831.92 |
Source: Dion Global
In the latest quarter, Windlas Biotech saw a rise in promoter holding to 63.31%, while DII stake decreased to 10.20%, FII holding rose to 0.99%, and public shareholding moved down to 25.49% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 8,57,651 | 1.1 | 73.06 | |
| 2,42,414 | 0.08 | 20.65 | |
| 2,00,000 | 0.19 | 17.04 | |
| 1,65,500 | 1.23 | 14.1 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| May 28, 2026, 07:16 PM IST IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript |
| May 22, 2026, 10:04 PM IST IST | Windlas Biotech - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2 |
| May 22, 2026, 12:09 AM IST IST | Windlas Biotech - Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulat |
| May 21, 2026, 11:08 PM IST IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| May 21, 2026, 10:56 PM IST IST | Windlas Biotech - Announcement under Regulation 30 (LODR)-Investor Presentation |
Source: Dion Global
Windlas Biotech Ltd. is a Public Limited Listed company incorporated on 19/02/2001 and has its registered office in the State of Uttarakhand/Uttaranchal, India. Company's Corporate Identification Number(CIN) is L74899UR2001PLC033407 and registration number is 033407. Currently Company is involved in the business activities of Manufacture of pulp, paper and paperboard. Company's Total Operating Revenue is Rs. 904.09 Cr. and Equity Capital is Rs. 10.55 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Windlas Biotech is ₹834.95 as on Jun 09, 2026.
The Windlas Biotech is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Windlas Biotech is ₹1,752.42 Cr as on Jun 09, 2026.
Today’s highest and lowest price of Windlas Biotech are ₹843.20 and ₹811.95.
The 52-week high/low is the highest and lowest price at which Windlas Biotech stock has traded in the past 52-week or nearly a year. The 52-week high of Windlas Biotech is ₹1,095.00 and 52-week low of Windlas Biotech is ₹699.35 as on Jun 09, 2026.
The Windlas Biotech has shown returns of 2.79% over the past day, 4.39% for the past month, 14.3% over 3 months, -9.37% over 1 year, 44.86% across 3 years, and 15.47% over 5 years.
P/E ratio of and PB ratio of Windlas Biotech are 26.37 and 3.19 on Jun 09, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global